Triple primary cancer of the head and neck, skin and prostate: A case report and literature review
- PMID: 30250595
- PMCID: PMC6144871
- DOI: 10.3892/ol.2018.9294
Triple primary cancer of the head and neck, skin and prostate: A case report and literature review
Abstract
Second primary cancer (SPC) is an important prognostic factor for patients with head and neck cancer (HNC); therefore, the association between the prognosis and development of SPC has been well-reported. The use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) is valuable to examine cancer stage, evaluate treatment responses and investigate suspected relapses or metastases. In the present study, the case of a male patient who was diagnosed with three primary cancer types, including well to moderately differentiated squamous cell carcinoma (SCC) of the mandible, axillary cutaneous poorly differentiated SCC and prostate adenocarcinoma, was described. Among these, mandible cancer was the first diagnosed when the patient was 70 years of age. Synchronous skin and prostate cancer (PRC) types then developed 3 years later. To the best of our knowledge, this is the first report of the aforementioned combination of cancer types. Postoperative FDG-PET was not performed as no lesions of recurrence or metastases of mandible cancer were found. Three years later, the PRC was asymptomatic and was incidentally detected by FDG-PET performed for a preoperative evaluation of skin cancer. It was indicated that FDG-PET could be utilized in patients with HNC due to there being no accurate FDG-PET protocol to detect SPC over a long-term follow-up.
Keywords: 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography; head and neck cancer; multiple primary neoplasms; prostate cancer; second primary; skin cancer.
Figures





Similar articles
-
More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003
-
Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.Ann Nucl Med. 2013 Dec;27(10):880-5. doi: 10.1007/s12149-013-0765-x. Epub 2013 Aug 25. Ann Nucl Med. 2013. PMID: 23979967
-
Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.Head Neck. 2017 Jun;39(6):1155-1165. doi: 10.1002/hed.24738. Epub 2017 Mar 6. Head Neck. 2017. PMID: 28263422
-
Positron emission tomography for prostate, bladder, and renal cancer.Semin Nucl Med. 2004 Oct;34(4):274-92. doi: 10.1053/j.semnuclmed.2004.06.004. Semin Nucl Med. 2004. PMID: 15493005 Review.
-
2-Deoxy-2-[18F] Fluoro-d-Glucose PET/Computed Tomography: Therapy Response Assessment in Head and Neck Cancer.PET Clin. 2022 Apr;17(2):307-317. doi: 10.1016/j.cpet.2021.12.003. Epub 2022 Mar 4. PET Clin. 2022. PMID: 35256300 Review.
References
-
- Cakir A, Akgun Z, Fayda M, Agaoglu F. Comparison of three dimensional conformal radiation therapy, intensity modulated radiation therapy and volumetric modulated arc therapy for low radiation exposure of normal tissue in patients with prostate cancer. Asian Pac J Cancer Prev. 2015;16:3365–3370. doi: 10.7314/APJCP.2015.16.8.3365. - DOI - PubMed
-
- IARC, corp-author. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. [Jun 16;2018 ];GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012.
-
- Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF., Jr . New malignancies among cancer survivors: SEER Cancer Registries, 1973–2000. National Cancer Institute; [Sep 18;2017 ].
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials